Abstracts ASN Report 2019

on account of radiation protection, or areas where nuclear waste can be produced. Some one hundred blocks of concrete resulting from the cutting-up phase of the “conventional” part of the reactor block are still present in the facility. Samples were taken from these ƫǼȒƬǸɀ ƏɎ Ɏǝƺ ƺȇƳ Ȓǔ א ׎׏ ژח ɎȒ ƬǝƺƬǸ ɎǝƏɎ Ɏǝƺ ȵǼƏȇȇƺƳ ƬǼƺƏȇ ٮ ȒɖɎ targets has been met. When the analysis results are received, which should be during the first half of 2020, and provided they are satisfactory, the last concrete blocks from the Ulysse reactor will be able to be removed. In 2020, the CEA will start the procedures aiming to delicence Ɏǝƺ ǔƏƬǣǼǣɎɵ ƏȇƳ ɯǣɎǝƳȸƏɯ ǣɎ ǔȸȒȅ Ɏǝƺ zX ژ ³ɵɀɎƺȅِ RǣǕǝ ٮ ǼƺɮƺǼ ƬɎǣɮǣɎɵ nƏƫȒȸƏɎȒȸɵ – CEA Centre The High-level Activity Laboratory (LHA) comprises several laboratories intended for research work or the production of ɮƏȸǣȒɖɀ ȸƏƳǣȒȇɖƬǼǣƳƺɀِ XɎ ƬȒȇɀɎǣɎɖɎƺɀ zX חגژ ِ…ȇ ƬȒȅȵǼƺɎǣȒȇ of the decommissioning and clean-out work authorised ƫɵ (ƺƬȸƺƺ Ȓǔ ׏ ژז ³ƺȵɎƺȅƫƺȸ א ׎׎ ז ً ȒȇǼɵ ɎɯȒ ǼƏƫȒȸƏɎȒȸǣƺɀ –currently in operation– should ultimately remain under the ICPE System. These two laboratories are the laboratory for the chemical and radiological characterisation of effluents and waste, and the packaging and storage facility for the retrieval of unused sources. Despite the progress of the clean-out and decommissioning operations, the accumulated delays have prevented the CEA ǔȸȒȅȅƺƺɎǣȇǕ Ɏǝƺ ƳƺƏƳǼǣȇƺ Ȓǔ א ׏ ژ ³ƺȵɎƺȅƫƺȸ א ׎׏ ژז ɀƺɎ ƫɵ Ɏǝƺ decree authorising LHA decommissioning. The discovery of ȵȒǼǼɖɎǣȒȇ ǣȇ ƬƺȸɎƏǣȇ ٹ ǣȇɎƺȸƬƺǼǼ ɵƏȸƳɀ ٺ ǣȇ א ׎׏ ژו ƏǼɀȒ ǼƺƳ ɎȒ ƬǝƏȇǕƺɀ beingmade in the operations to be carried out. Investigations into the radiological status of the soils were carried out during 2019, with results expected in 2020. The licensee must submit a decommissioning decree modification file. It must include the justification of the time required to complete the decommissioning operations authorised by the Decree of ׏ ژז ³ƺȵɎƺȅƫƺȸ זא ِ XɎɀ ɀɖƫȅǣɀɀǣȒȇ ǣɀ ȵǼƏȇȇƺƳ ǔȒȸ ȅǣƳ אٮ ׎ א ׏ِ ³z will be attentive to the progress of the studies planned prior to submission of the file. ǼȒȇǕɀǣƳƺ Ɏǝǣɀً Ɏǝƺ ɵƺƏȸ א ׎׏ ژח ɀƏɯ Ɏǝƺ ɀɎȒȵȵǣȇǕ Ȓǔ Ə ǼƏȸǕƺ part of the decommissioning and clean-out operations, the safeguarding and teardown of the worksites, in relation with the CEA’s decommissioning and waste management strategy examined by ASN (see chapter 13). ³z ƬȒȇɀǣƳƺȸɀ ɎǝƏɎ Ɏǝƺ ǼƺɮƺǼ Ȓǔ ɀƏǔƺɎɵ Ȓǔ zX ژחגژ ɖȇƳƺȸǕȒǣȇǕ decommissioning is satisfactory. The inspections of the facility confirmed the setting up of corrective measures further ɎȒ Ɏǝƺ ɀǣǕȇǣǔǣƬƏȇɎ ƺɮƺȇɎɀ ǣȇ א ׎׏ ژז ǼǣȇǸƺƳ ɎȒ Ɏǝƺ ǔǣȸƺ ȸǣɀǸِ Áǝƺɵ also confirmed the strong involvement of the licensee in the management of safety, particularly in the monitoring of worksites. In addition, the measures taken by the CEA for controlling detrimental effects were found to be satisfactory. This being said, the monitoring of hazardous substances in the facility must be improved. Vigilance is also required with the proper characterisation of deviations and the tracking of the continuous improvements sheets. ȸɎǣˡƬǣƏǼ «ƏƳǣȒȇɖƬǼǣƳƺ ¨ȸȒƳɖƬɎǣȒȇ ¨ǼƏȇɎ Ȓǔ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼ Áǝƺ Ȩ« ƬȒȇɀɎǣɎɖɎƺɀ zX חאژ ِ XɎ ɯƏɀ ƬȒȅȅǣɀɀǣȒȇƺƳ ǣȇ ׏ ژגהח Ȓȇ Ɏǝƺ ³ƏƬǼƏɵ ɀǣɎƺ ƫɵ Ɏǝƺ !0 ً ɯǝǣƬǝ ǣȇ ׏ חח ׎ ژ ƬȸƺƏɎƺƳ Ɏǝƺ !X³ ژ ƫǣȒ international subsidiary, the current licensee. In the early 2000’s, this subsidiary was bought up by several companies specialising in nuclear medicine. In 2017, the parent company Ȓǔ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼ ƏƬȷɖǣȸƺƳ xƏǼǼǣȇƬǸȸȒƳɎ zɖƬǼƺƏȸ Medicine LCC, now forming the Curium group, which owns three production sites (in the United States, France, and Ɏǝƺ ژ zƺɎǝƺȸǼƏȇƳɀ٣ِ The CuriumGroup is an important player on the French and international market for the production and development of radiopharmaceutical products. The products are mainly used for the purposes of medical diagnoses, but also for therapeutic ɖɀƺɀِ ÈȇɎǣǼ א ׎׏ ח ً Ɏǝƺ ȸȒǼƺ Ȓǔ zX ژחאژ ɯƏɀ ƏǼɀȒ ɎȒ ȸƺƬȒɮƺȸ ƳǣɀɖɀƺƳ sealed sources which were used for radiotherapy and industrial ǣȸȸƏƳǣƏɎǣȒȇِ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼ ǝƏɀ ȅƏƳƺ ǕȒȒƳ ȵȸȒǕȸƺɀɀ ɯǣɎǝ the removal of disused high-activity sealed sources that are stored in the facility. The group has moreover decided to stop its iodine-131-based productions on the Saclay site, which will significantly reduce the consequences of accident situations. !ȒȇɎȸȒǼ Ȓǔ ɖȸƫƏȇǣɀƏɎǣȒȇ ƏȸȒɖȇƳ Ɏǝƺ ³ƏƬǼƏɵ ɀǣɎƺ Áǝƺ !0 ٫³ƏǣȇɎ ٮ ɖƫǣȇ ɀɎƏɎǣȒȇ ȵȸȒǴƺƬɎً Ȓȇ Ɏǝƺ ȸȒɖɎƺ of the future line 18, is situated at the “ Le Christ de Saclay ” roundabout. This project is not compatible with the town-planning restrictions currently in effect. At present, the control of urbanisation around Saclay ǣɀ ژ ƫƏɀƺƳ Ȓȇ ǝƏɿƏȸƳ ɿȒȇƺɀ ȸƺɀɖǼɎǣȇǕ ǔȸȒȅ ɀɎɖƳǣƺɀ ɎǝƏɎ used hypotheses that are no longer relevant, given the changes in the Basic Nuclear Installations (BNIs) of the !0 ƏȇƳ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼِ ³z ǝƏƳ ɎǝƺȸƺǔȒȸƺ ƏɀǸƺƳ Ɏǝƺ !0 ƏȇƳ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼ ɎȒ ɖȵƳƏɎƺ Ɏǝƺɀƺ ɀɎɖƳǣƺɀ to assess the impacts of these BNIs on the line 18 project. These updates, which take into account the shutdown of the Orphée reactor and removal of the iodine-131 ǔȸȒȅ Ɏǝƺ !X³ ژ ƫǣȒ ǣȇɎƺȸȇƏɎǣȒȇƏǼ ǔƏƬǣǼǣɎɵً ƳȒ ȇȒɎ ɀǝȒɯ any hazard zones reaching the station. The examination carried out by ASN confirms these results. In 2020, ASN will state its position on the effective reduction of the risks induced by the site’s BNIs, which enable the provisions for controlling urbanisation to be revised. ASN Report on the state of nuclear safety and radiation protection in France in 2019 65 REGIONAL OVERVIEWOF NUCLEAR SAFETY AND RADIATION PROTECTION \n0 (ٳ 0 ٳ I« z!0